UA85725U - Способ лечения патологии шейки матки - Google Patents
Способ лечения патологии шейки матки Download PDFInfo
- Publication number
- UA85725U UA85725U UAU201307712U UAU201307712U UA85725U UA 85725 U UA85725 U UA 85725U UA U201307712 U UAU201307712 U UA U201307712U UA U201307712 U UAU201307712 U UA U201307712U UA 85725 U UA85725 U UA 85725U
- Authority
- UA
- Ukraine
- Prior art keywords
- cryodestruction
- pathology
- cervix
- day
- intravaginally
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- 210000003679 cervix uteri Anatomy 0.000 title claims abstract description 12
- 230000007170 pathology Effects 0.000 title claims abstract description 10
- 238000002347 injection Methods 0.000 claims abstract description 8
- 239000007924 injection Substances 0.000 claims abstract description 8
- 230000001575 pathological effect Effects 0.000 claims abstract description 5
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 4
- 239000000829 suppository Substances 0.000 claims abstract description 3
- 241001631646 Papillomaviridae Species 0.000 claims abstract 2
- 108010037519 Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu Proteins 0.000 abstract description 4
- 108010078049 Interferon alpha-2 Proteins 0.000 abstract 1
- 241000701806 Human papillomavirus Species 0.000 description 11
- 238000011282 treatment Methods 0.000 description 10
- 206010008342 Cervix carcinoma Diseases 0.000 description 9
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 9
- 201000010881 cervical cancer Diseases 0.000 description 9
- 206010008263 Cervical dysplasia Diseases 0.000 description 5
- 206010058314 Dysplasia Diseases 0.000 description 5
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 description 5
- 230000008569 process Effects 0.000 description 4
- 208000009608 Papillomavirus Infections Diseases 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 230000004913 activation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 229940124622 immune-modulator drug Drugs 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000002741 leukoplakia Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 230000000771 oncological effect Effects 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ лечения патологии шейки матки заключается в том, что женщине с патологией шейки матки, связанной с вирусом папилломы, проводят комплексную терапию. Назначают введение виферон-ферона по 1 суппозиторию 500 000 МЕ 2 раза в день внутривагинально 10 дней. Затем проводят криодеструкцию патологического очага на шейке, вводят иммуномакс по 200 ед. внутримышечно 6 инъекций в 2 этапа: 3 инъекции до криодеструкции, 3 инъекции после криодеструкции и со 2-го дня после криодеструкции внутривагинально вводят тампоны с Гепоном 10 дней.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201307712U UA85725U (ru) | 2013-06-17 | 2013-06-17 | Способ лечения патологии шейки матки |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201307712U UA85725U (ru) | 2013-06-17 | 2013-06-17 | Способ лечения патологии шейки матки |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA85725U true UA85725U (ru) | 2013-11-25 |
Family
ID=52285243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201307712U UA85725U (ru) | 2013-06-17 | 2013-06-17 | Способ лечения патологии шейки матки |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA85725U (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2635518C2 (ru) * | 2016-04-18 | 2017-11-13 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ лечения хронического эндометрита с аутоиммунными нарушениями эндометрия |
-
2013
- 2013-06-17 UA UAU201307712U patent/UA85725U/ru unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2635518C2 (ru) * | 2016-04-18 | 2017-11-13 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ лечения хронического эндометрита с аутоиммунными нарушениями эндометрия |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rahangdale et al. | Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial | |
| Boyd | Condylomata acuminata in the pediatric population | |
| Klencke et al. | Anal cancer: an HIV-associated cancer | |
| Cox et al. | Using imiquimod for genital warts in female patients | |
| UA85725U (ru) | Способ лечения патологии шейки матки | |
| Androphy | Papillomaviruses and interferon | |
| Al-Azmi et al. | Human papillomavirus: manifestations, prevention and treatment: an overview | |
| Nahas et al. | Prevalence of perianal intraepithelial neoplasia in HIV-infected patients referred for high-resolution anoscopy | |
| DK1439845T3 (en) | INACTIVATION OF PAPILLOMAVIRUS | |
| RU2327485C1 (ru) | Способ леченеия эктопии шейки матки | |
| Dworak et al. | Hamartoma of an ectopic breast arising in the inguinal region | |
| Bornstein et al. | Development of vaginal adenosis following combined 5-fluorouracil and carbon dioxide laser treatments for diffuse vaginal condylomatosis | |
| Ordiyants et al. | Recurrence of HPV infection after combination therapy of uterine cervical diseases | |
| Fox et al. | Anogenital warts, intraepithelial neoplasia, and their clinical management | |
| Passos | Infection with human papillomavirus (HPV) | |
| Cook et al. | Condyloma | |
| Leung | Genital warts-current issues | |
| Chayachinda et al. | A never-ending story of anogenital warts | |
| Chen et al. | A Prospective Multi-Center Controlled Study of Gaoweikang (Chinese Multi-Herb Extracts Based Potion) On High-Risk HPV Infection | |
| Du | The Treatment of HPV-Induced Cervical Cancers | |
| An et al. | IMPROVEMENT OF TACTICS FOR THE MANAGEMENT CERVICITIS ASSOCIATED WITH PAPILLOMAVIRUS INFECTION IN WOMEN OF REPRODUCTIVE AGE | |
| Rogovskaya et al. | Combination therapy with depantol and lavomax for diseases of the cervix uteri | |
| Matiluko | Cervical ectropion. Part 1: appraisal of a common clinical finding | |
| Chen et al. | Prospective cohort study of 5-aminolevulinic acid photodynamic therapy for cervical low-grade squamous intraepithelial lesions with human papillomavirus infection | |
| Ibragimova et al. | Assessing survival rate of HPV-positive and HPV-negative cervical cancer patients |